aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Unnatural Products, founded with the mission to revolutionize drug discovery, leverages AI-enhanced technology to develop novel drugs targeting previously undruggable proteins. The company specializes in engineering passively permeable, macrocyclic peptides that can reach complex drug targets beyond the capabilities of traditional small molecules and biologics. Their innovative approach aims to address a significant portion of drug targets that impact human health but have remained out of reach for existing therapeutic modalities.
Notable figures affiliated with Unnatural Products include leading experts in AI and drug discovery, though specific names are not provided. The company has attracted significant attention and investment from key players in the biotech and pharmaceutical industries. Their pioneering work in creating macrocyclic peptides has positioned them as a transformative force in the field, potentially unlocking treatments for a wide array of conditions previously deemed untreatable.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private Equity
Main Product(s)
Drug Discovery, Drug Development
Technology
AI, Machine Learning
Tags
Biotech, Healthtech, Ai Operations
Model Types
Platform, Software, Research Development
Revenue Type(s)
Consulting
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
Global
When was Unnatural Products founded?
Unnatural Products was founded in 2017.
Where is Unnatural Products's headquarters located?
Unnatural Products's headquarters is located in Santa Cruz, CA, US.
When was Unnatural Products's last funding round?
Unnatural Products's most recent funding round was for $32M (USD) in December 2023.
How many employees does Unnatural Products have?
Unnatural Products has 36 employees as of Feb 5, 2024.
How much has Unnatural Products raised to-date?
As of July 05, 2023, Unnatural Products has raised a total of $38M (USD) since Dec 19, 2023.
Add Comparison
Total Raised to Date
$38M
USD
Last Update Dec 19, 2023
Last Deal Details
$32M
USD
Dec 19, 2023
Series A
Total Employees Over Time
36
As of Feb 2024
Unnatural Products Address
Santa Cruz,
California
95061
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts